Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT01548482 · COMPLETED

Trial details

NCT number: NCT01548482
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Solid Neoplasm Lung Carcinoid Tumor Recurrent Digestive System Neuroendocrine Tumor G1 Recurrent Renal Cell Carcinoma Recurrent Uterine Corpus Sarcoma Stage III Renal Cell Cancer Stage IIIB Uterine Sarcoma Stage IIIC Uterine Sarcoma Stage IV Renal Cell Cancer Stage IVA Uterine Sarcoma Stage IVB Uterine Sarcoma

Start date: 2012-03-01
Primary completion: 2014-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.